type_of_cancer: rms
cancer_study_identifier: soft_tissue_msk_2023
name: Sequential Rhabdomyosarcomas (MSK, Nature Precision Oncology 2023)
description: Targeted sequencing of 42 rhabdomyosarcoma tumors and their matched normals via MSK-IMPACT.